Travere Therapeutics, Inc. (TVTX)
55.89
-1.78
(-3.09%)
USD |
NASDAQ |
Oct 06, 15:42
Travere Therapeutics Profit Margin (Quarterly) : -20.52% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.52% |
| March 31, 2026 | -28.78% |
| December 31, 2025 | -16.95% |
| September 30, 2025 | 15.59% |
| June 30, 2025 | -11.14% |
| March 31, 2025 | -50.44% |
| December 31, 2024 | -80.59% |
| September 30, 2024 | -87.05% |
| June 30, 2024 | -128.7% |
| March 31, 2024 | -328.6% |
| December 31, 2023 | -196.6% |
| September 30, 2023 | -240.6% |
| June 30, 2023 | -143.4% |
| March 31, 2023 | -312.6% |
| December 31, 2022 | -291.9% |
| September 30, 2022 | -299.4% |
| June 30, 2022 | -123.8% |
| March 31, 2022 | -156.7% |
| December 31, 2021 | -90.09% |
| September 30, 2021 | -52.24% |
| June 30, 2021 | -71.43% |
| March 31, 2021 | -113.6% |
| December 31, 2020 | -238.6% |
| September 30, 2020 | -44.09% |
| June 30, 2020 | -53.83% |
| Date | Value |
|---|---|
| March 31, 2020 | 1.69% |
| December 31, 2019 | -64.81% |
| September 30, 2019 | -82.23% |
| June 30, 2019 | -86.57% |
| March 31, 2019 | -103.6% |
| December 31, 2018 | -17.03% |
| September 30, 2018 | -133.9% |
| June 30, 2018 | -54.02% |
| March 31, 2018 | -47.82% |
| December 31, 2017 | -41.77% |
| September 30, 2017 | -44.11% |
| June 30, 2017 | -34.10% |
| March 31, 2017 | -32.99% |
| December 31, 2016 | -23.05% |
| September 30, 2016 | -109.3% |
| June 30, 2016 | -40.24% |
| March 31, 2016 | 38.67% |
| December 31, 2015 | -8.11% |
| September 30, 2015 | |
| June 30, 2015 | -106.1% |
| March 31, 2015 | |
| December 31, 2014 | -206.1% |
| September 30, 2014 | -234.2% |
| June 30, 2014 | |
| March 31, 2014 | -253.1K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 4.49% |
| TG Therapeutics, Inc. | 3.24% |
| Krystal Biotech, Inc. | 45.94% |
| RenovoRx, Inc. | -320.2% |
| Pelthos Therapeutics, Inc. | -150.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -98.26% |
| Return on Assets | -11.08% |
| Return on Invested Capital | -14.42% |
| Gross Profit Margin (Quarterly) | 96.22% |
| Operating Margin (Quarterly) | 2.33% |
| Return on Net Operating Assets | -32.46% |